Toshiaki Taoka1, Hisashi Kawai1, Toshiki Nakane1, Toshiteru Miyasaka2, and Shinji Naganawa1
1Radiology, Nagoya University, Nagoya, Japan, 2Radiology, Nara Medical University, Kashihara, Japan
Synopsis
Permeability images can provide additional
information to perfusion images in the clinical practice of brain tumors.
However, permeability imaging by dynamic contrast enhancement methods requires
a long acquisition time. K2 is an index that represents permeability and can be
calculated from the dataset of perfusion images with the dynamic susceptibility
contrast method, which requires a short acquisition time. In the current study,
we calculated K2 for various grades of gliomas and found that K2 showed a
significantly higher 20th percentile value in Grade IV compared to Grade III
gliomas, providing useful information for grading of gliomas.Purpose
Permeability
imaging by the dynamic contrast enhancement (DCE) method can provide Ktrans, which
is useful in glioma grading. However, DCE methods require long imaging times of
up to 10 minutes. Tissue permeability can also be calculated using the
dynamic susceptibility contrast (DSC) method, which can be performed in the
first pass time window. K2 is an index that represents permeability and can be
calculated from the dataset obtained with the DSC method. The purpose of the
current study is to evaluate the usefulness of K2 obtained with the DSC method
for grading of gliomas, as well as relative cerebral blood volume (rCBV) from
the same datasets. We also measured DCE to calculate Ktrans and evaluate the
correlation with K2.
Methods
[Cases] Twenty-two patients with glioma (Grade II:
5, III: 6, IV: 11) underwent DSC studies, including eight patients in which
both DSC and DCE studies were performed within 10 days, but on different days.
[Imaging] Imaging was performed with 3-T magnetic resonance imaging (MRI) (Siemens
MAGNETOM Verio). DSC perfusion datasets were acquired using the EPI sequence
(TR/TE = 1370/35 ms), and DCE permeability datasets were acquired using the
gradient echo sequence (TR/TE = 3.88/1.31 ms, FA = 12 deg).
[Post-processing] K2, rCBV, and
Ktrans were calculated using post-processing software Olea Sphere v2.3 (Olea
Medical, La Ciotat, France). Ktrans computations were made with the Extended
Tofts method
[Ref. 1], and K2 and rCBV computations with leakage correction were
made with the Boxerman method
[Ref. 2].
[Analysis] We placed regions of interest (ROIs) on
the tumor based on Response Assessment in Neuro-Oncology WG (RANO) criteria
[Ref. 3]. Thus, for a "measurable tumor" with contrast enhancing
lesions with clearly defined margins, we placed the ROI on contrast enhancing
MRI, and for a "non-measurable tumor" without clearly defined margins
on contrast MRI, we placed the ROI on FLAIR (Fig. 1). We performed histogram
analysis of ROIs of the tumors and acquired 20th percentile values for
leakage-corrected CBV (CBV20%ile), K2 (K220%ile), and for cases with a DCE study,
Ktrans (Ktrans20%ile). We analyzed
(1) the correlation between K220%ile and
Ktrans20%ile and
(2) the statistical difference between CBV20%ile and K220%ile
values among glioma grades (II, III, and IV).
(3) We also performed the same
post-processing for the 5%ile, 10%ile, 15%ile, 30%ile, and the mean values of
the same ROIs and performed receiver-operating characteristic (ROC) analysis
for grading gliomas (II vs. III and III vs. IV) by rCBV and K2.
Results
(1) We
found a statistically significant correlation between K2 and Ktrans (r = 0.717,
p < 0.05, Fig. 2).
(2) CBV was significantly different between Grades II and
III, and between Grades II and IV. K2 was significantly different (p < 0.05)
between Grades II and IV, and between Grades III and IV (Fig. 3).
(3) ROC
analysis (Fig. 4) indicated that the area under the curve for discrimination
between Grades II and III by CBV was:
5%ile: 0.83, 10%ile: 0.77,
15%ile: 0.87,
20%ile: 0.87, 30%ile: 0.87, mean value: 0.87. For K2, analysis showed: 5%ile:
0.53, 10%ile: 0.60, 15%ile: 0.67, 20%ile: 0.70, 30%ile: 0.78, mean value: 0.73.
Similarly, discrimination between Grades III and IV by CBV was: 5%ile: 0.67,
10%ile: 0.59, 15%ile: 0.59, 20%ile: 0.53, 30%ile: 0.58, mean value: 0.53. For
K2, analysis showed:
5%ile: 0.89 10%ile: 0.91, 15%ile: 0.94, 20%ile: 0.91,
30%ile: 0.86, mean value: 0.32. (Underlined values are >0.8.)
Discussion
K2
is a byproduct of the mathematical leakage correction process and refers to the
leakage rate detected in the DSC method. Although quantitative interpretation
of K2 is complex, it is proportional to the vascular permeability. Here, Ktrans
with the DCE method and K2 with the DSC method correlated well when compared
using histogram analysis. The CBV value with the DSC method showed a statistically
significant difference between Grades II and III, both in mean value and with
histogram analysis. In contrast, the K2 value with the DSC method showed a
statistically significant difference between Grades III and IV only in
histogram analysis. Thus, the K2 value obtained with the DSC method can be used
as a substitute for Ktrans with the DCE method when histogram analysis
(~30%ile) is performed.
Conclusion
The K2 value calculated from the DSC
dataset, which can be obtained with a short acquisition time, was correlated
with Ktrans obtained with the DCE method and seems useful for glioma grading,
especially for discrimination between Grades III and IV when evaluated using
histogram analysis.
Acknowledgements
No acknowledgement found.References
1. Tofts PS et al. J Magn Reson Imaging. 1999; 10:223-32.
2. Boxerman JL et al. AJNR 2006; 27:859-67.
3. Wen PY et al. J Clin Oncol 2010; 28:1963-1972.